NCT00329823View on ClinicalTrials.gov

Etanercept in Hidradenitis Suppurativa

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

May 31, 2006

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

Etanercept sc 50mg per week for 12 weeks

Trial Locations (1)

124 64

4th Department of Internal Medicine, University of Athens, Medical School, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT00329823 - Etanercept in Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter